Therapy of cutaneous lupus erythematosus.
Cutaneous lupus erythematosus occurs in a spectrum from limited cutaneous disease to severe systemic disease. Chronic DLE generally follows a benign course, but rare transformation to systemic disease may occur. Subacute cutaneous LE is associated with a specific cutaneous lesion and mild to moderate systemic symptoms. Cutaneous disease should be managed by an experienced physician and can lead to control of the process.
D000962:Antimalarials / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008179:Lupus Erythematosus, Discoid / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D013473:Sunscreening Agents / Q000627:therapeutic use
D000962:Antimalarials; D005938:Glucocorticoids; D013473:Sunscreening Agents